Chimeric Human Papillomavirus (hpv) L1 Molecules And Uses Therefor


The full document isn't yet available to us from the patent office.


Disclosed are chimeric HPV L1 proteins and virus like particles comprising the same which are capable of generating high titer neutralizing antibody responses against at least two HPV types. The disclosed chimeric HPV L1 proteins and VLPs are useful as therepeutic and prophylactic reagents, as well as reagents for diagnosing papillomavirus infection.


Information currently unavailable.

IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jul 23, 2008
  • Application: Jun 12, 2001
    EP EP 07024862 A
  • Priority: Jun 12, 2001
    EP EP 01942170 A
  • Priority: Jun 21, 2000
    US US 21283900 P

Download Citation

Sign in to the Lens